DE3274243D1 - Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them - Google Patents

Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
DE3274243D1
DE3274243D1 DE8282200130T DE3274243T DE3274243D1 DE 3274243 D1 DE3274243 D1 DE 3274243D1 DE 8282200130 T DE8282200130 T DE 8282200130T DE 3274243 T DE3274243 T DE 3274243T DE 3274243 D1 DE3274243 D1 DE 3274243D1
Authority
DE
Germany
Prior art keywords
erythromycin
preparation
pharmaceutical compositions
compositions containing
therapeutic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282200130T
Other languages
English (en)
Inventor
Jacques Dr Gonella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REFARMED CHEMICALS LTD., LUGANO, CH
Original Assignee
REFARMED RECH PHARM MED
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REFARMED RECH PHARM MED filed Critical REFARMED RECH PHARM MED
Application granted granted Critical
Publication of DE3274243D1 publication Critical patent/DE3274243D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8282200130T 1981-02-02 1982-02-01 Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them Expired DE3274243D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8101930A FR2502627A1 (fr) 1981-02-02 1981-02-02 Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent

Publications (1)

Publication Number Publication Date
DE3274243D1 true DE3274243D1 (en) 1987-01-02

Family

ID=9254718

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8282200131T Expired DE3262069D1 (en) 1981-02-02 1982-02-01 Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them
DE8282200130T Expired DE3274243D1 (en) 1981-02-02 1982-02-01 Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8282200131T Expired DE3262069D1 (en) 1981-02-02 1982-02-01 Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them

Country Status (7)

Country Link
US (1) US4393053A (de)
EP (3) EP0060573B1 (de)
JP (3) JPS57176997A (de)
AT (2) ATE43347T1 (de)
DE (2) DE3262069D1 (de)
ES (1) ES510030A0 (de)
FR (1) FR2502627A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1163108B (it) * 1983-02-16 1987-04-08 Corvi Camillo Spa Sale di eritromicina dell'acido benzoico-o-carboniltiazolidina,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1164255B (it) * 1983-05-30 1987-04-08 Pavese Ist Biochim Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5333914A (en) * 1992-01-17 1994-08-02 Toyoda Gosei Co., Ltd. Hose device
WO1996019489A1 (en) * 1994-12-19 1996-06-27 Russinsky Limited Compounds
CA2255124A1 (en) * 1996-08-07 1998-02-12 Helmut Schickaneder A process for the production of pharmaceuticals
TWI250019B (en) 1998-08-18 2006-03-01 Univ California Preventing airway mucus production by administration of EGF-R antagonists
CA2346870A1 (en) 1998-10-20 2000-04-27 Lauteral Limited Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity
US7923047B2 (en) 2006-06-30 2011-04-12 Conagra Foods Rdm, Inc. Seasoning and method for seasoning a food product while reducing dietary sodium intake

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) * 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US2743268A (en) * 1952-07-12 1956-04-24 Lilly Co Eli Erythromycin-penicillin
US2830982A (en) * 1955-06-03 1958-04-15 Abbott Lab Water-soluble salt of erythromycin
FR1465403A (fr) * 1965-07-02 1967-01-13 Roussel Uclaf Nouveau sel d'érythromycine et procédé de préparation
US3558594A (en) * 1968-09-04 1971-01-26 Abbott Lab Erythromycin aliphatic sulfate
US3843787A (en) * 1969-01-15 1974-10-22 Pierrel Spa Water soluble derivative of erythromycin
GB1250045A (en) * 1969-01-15 1971-10-20 Pierrel Spa A new water soluble derivative of erythromycin
US3847896A (en) * 1973-04-09 1974-11-12 Upjohn Co Erythromycin-2-thiol esters and process
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
US4261982A (en) * 1977-11-09 1981-04-14 The Procter & Gamble Company Therapeutic composition
CA1121825A (en) * 1978-04-11 1982-04-13 Franco Bolasco 2-(2-thenoylthio)-propionylglycine: method for its preparation and pharmaceutical formulations containing said compound
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters
IT1148890B (it) * 1980-07-22 1986-12-03 Neopharmed Spa Derivato della teonil tiopropionil glicina e procedimento per la sua preparazione

Also Published As

Publication number Publication date
EP0057489A1 (de) 1982-08-11
ES8305001A1 (es) 1983-04-01
JPH0216320B2 (de) 1990-04-16
ES510030A0 (es) 1983-04-01
EP0174395A3 (en) 1986-08-27
JPS57176997A (en) 1982-10-30
JPH0317840B2 (de) 1991-03-11
ATE43347T1 (de) 1989-06-15
JPH0216758B2 (de) 1990-04-18
EP0057489B1 (de) 1986-11-12
EP0174395A2 (de) 1986-03-19
JPS57176996A (en) 1982-10-30
EP0060573B1 (de) 1985-01-30
EP0174395B1 (de) 1989-05-24
JPS60132999A (ja) 1985-07-16
US4393053A (en) 1983-07-12
FR2502627A1 (fr) 1982-10-01
DE3262069D1 (en) 1985-03-14
ATE11546T1 (de) 1985-02-15
EP0060573A1 (de) 1982-09-22

Similar Documents

Publication Publication Date Title
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
DE3375137D1 (en) Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
AU556039B2 (en) I.v. therapy or hyperalimentation catheter
JPS55141407A (en) Nonoral administration solution containing arylacetic acid or arylpropionic acid derivative
IL109578A0 (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
DE3262069D1 (en) Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
JPS5661374A (en) Cytostatic drug* novel cyanuric acid derivative and manufacture thereof
ES8305378A1 (es) "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".
GB2199746B (en) Stabilization of antibiotic compositions with salts.
NO912545D0 (no) Nye 3,3'-ditobis (propionsyrer) og estere derav samt fremgangsmaate for dens fremstilling.
AU617998B2 (en) Anticoccidial composition
NZ195058A (en) 2b-acetoxymethyl-(5r)-2-methyl-penam-3-carboxylic acid 1, 1-dioxide and salts and esters thereof pharmaceutical compositions
DE3164719D1 (en) Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation
DE3270446D1 (en) Diamides of substituted hydroxymalonic acids, process for their preparation and their use as pesticides
ZA881561B (en) Substituted pyridine-2,4-dicarboxylic acid derivatives,processes for their preparation,the use thereof and medicaments based on these compounds
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
ES8201578A1 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
GB2101600B (en) 2,4-hexadienoic acid derivatives useful as weed-killers and phytogrowth regulators
JPS57203064A (en) Amide derivative, manufacture and pharmaceutical composition containing same and having gastric acid secretion control activity
ES8200363A1 (es) Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
IL56442A (en) Solvent vehicle for the parenteral administration of therapeutics containing an adipic acid ester,pharmaceutical compositions comprising said vehicle and their use in the prophylaxis and/or treatment of certain diseases
JPS5643283A (en) Betaacarbolinee33carboxylic acid derivative* its manufacture and psychotic medicine containing it
ES8505383A1 (es) Procedimiento para la preparacion de sales de eritromicina, o sus esteres, con derivados acidos de la inosina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: ERYTHROMYCINSTINOPRAT; REGISTRATION NO/DATE: 16195.00.00, 16195.01.00, 16197.00.00, 16198.00.00, 16198.01.00; 19910717

Spc suppl protection certif: 193 75 093

Filing date: 19930701

V457 Spc granted

Free format text: PRODUCT NAME: ERYTHROMYCINSTINOPRAT; REGISTRATION NO/DATE: 16195.00.00, 16195.01.00, 16197.00.00, 16198.00.00, 16198.01.00; 19910717

Spc suppl protection certif: 193 75 093

Filing date: 19930701

8327 Change in the person/name/address of the patent owner

Owner name: REFARMED CHEMICALS LTD., LUGANO, CH

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

V465 Spc lapsed due to nonpayment of the annual fee

Free format text: PRODUCT NAME: ERYTHROMYCINSTINOPRAT; REGISTRATION NO/DATE: 16195.00.00, 16195.01.00, 16197.00.00, 16198.00.00, 16198.01.00; 19910717

Spc suppl protection certif: 193 75 093

Filing date: 19930701